BPC-157

What it is (in plain language)
- Think of it as the body's 'master builder'. BPC-157 radically accelerates the healing of tendons, ligaments, muscles and even bones. It also plays a vital role in protecting the gastrointestinal tract, helping to heal ulcers and combat Leaky Gut Syndrome through angiogenesis (the creation of new blood vessels).

Why do you appear online so much
- It's probably the most famous peptide in the world. High-performance athletes and biohackers use it to recover from injuries that would normally take months in just a few weeks. Its versatility (it can be used orally or injected) and its protective effects against damage caused by anti-inflammatory drugs (NSAIDs) make it essential in any recovery protocol.

How it is framed today (pragmatic view)
- 1) Evidence: Extensive in animal models with impressive results; in humans, the data is based on decades of off-label clinical use with a high success rate. 2) Purpose: Soft tissue repair and digestive health. 3) Risk: Due to its ability to promote blood vessels, caution should be exercised in individuals with a history of active neoplasms.

How to use this form
- Explore the interactions section to understand how BPC-157 interacts with the dopaminergic system and tissue healing.

- Quick profile (curated by Subject 157)
- Class: Repair
- Status: Verified
- Use case: Repair
- Route: Injectable
- Tags: Injectable|Oral|Gut|Tendons
- Half-life: ~4 Hours
- Start: Fast
- Duration: ~24 hours

- Mechanism (high level)
Peptide isolated from human gastric juice (Body Protection Compound). Accelerates angiogenesis via the VEGFR2 receptor and modulates the NO (Nitric Oxide) pathway, promoting repair of tendons, ligaments and intestinal mucosa.

- Evidence (what the literature covers)
RESEARCH RANGE (Non-prescriptive):
Common doses range from 250mcg to 500mcg (1-2x daily).
Level of Evidence: B (Robust animal studies, limited but promising human trials).

- Safety and harm-reduction (non-prescriptive)
Risks: No serious adverse effects reported in studies.
Interactions: Unknown.

- References (anchors)
- Chang, C. (2011) - BPC 157 tendon healing model - https://doi.org/10.1152/japplphysiol.00945.2010 | PubMed:21030672
- Sikiric, P. (2014) - BPC 157 and nitric oxide system review - https://doi.org/10.2174/13816128113190990411 | PubMed:23782145

Note: Educational/research content. Does not constitute medical advice, diagnosis or prescription.